Literature DB >> 17031575

Overexpression of BLCAP induces S phase arrest and apoptosis independent of p53 and NF-kappaB in human tongue carcinoma : BLCAP overexpression induces S phase arrest and apoptosis.

Jun Yao1, Li Duan, Mingwen Fan, Jianhuan Yuan, Xinxing Wu.   

Abstract

Bladder cancer-associated protein gene (BLCAP) is a novel candidate tumor suppressor gene identified from the human bladder carcinoma. Our previous studies have shown that BLCAP overexpression could inhibit cell growth by inducing apoptosis in HeLa cells [Zuo Z, Zhao M, Liu J, Gao G, Wu X: Tumor Biol 27: 221-226, 2006]. Such evidence suggests the alterations in BLCAP may play an important role in tumorigenesis. To further study the biological function of the BLCAP gene, we constructed a recombinant retroviral vector encoding BLCAP cDNA. Overexpressed BLCAP, via stable infection of exogenous BLCAP, resulted in growth inhibition of the human tongue cancer cell line Tca8113 in vitro, accompanied by S phase cell cycle arrest and apoptosis. The growth inhibition was correlated with up-regulation of p21(WAF1/CIP1 )expression and down-regulation of Bcl-XL and Bcl-2 expressions. However, p53 expression and NF-kappaB activity remained unchanged post infection. Furthermore, no changes in p53 phosphorylation at Ser46 and nuclear localization, which are critical to p53 function, were observed in BLCAP-overexpressed cells. Taken together, BLCAP may play a role not only in regulating cell proliferation but also in coordinating apoptosis and cell cycle via a novel way independent of p53 and NF-kappaB.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17031575     DOI: 10.1007/s11010-006-9332-2

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  31 in total

1.  Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer.

Authors:  J P Pignon; J Bourhis; C Domenge; L Designé
Journal:  Lancet       Date:  2000-03-18       Impact factor: 79.321

2.  Characterization of cell clones stably transfected with short form caspase-9: apoptotic resistance and Bcl-XL expression.

Authors:  Xiaolan Yi; Jinzhao Wang; Dai-Wu Seol; Zheng Dong
Journal:  Mol Cell Biochem       Date:  2006-01       Impact factor: 3.396

3.  The p21(WAF1/CIP1) promoter is methylated in Rat-1 cells: stable restoration of p53-dependent p21(WAF1/CIP1) expression after transfection of a genomic clone containing the p21(WAF1/CIP1) gene.

Authors:  L A Allan; T Duhig; M Read; M Fried
Journal:  Mol Cell Biol       Date:  2000-02       Impact factor: 4.272

4.  Apoptosis or senescence-like growth arrest: influence of cell-cycle position, p53, p21 and bax in H2O2 response of normal human fibroblasts.

Authors:  Q M Chen; J Liu; J B Merrett
Journal:  Biochem J       Date:  2000-04-15       Impact factor: 3.857

5.  Cancer statistics, 1999.

Authors:  S H Landis; T Murray; S Bolden; P A Wingo
Journal:  CA Cancer J Clin       Date:  1999 Jan-Feb       Impact factor: 508.702

6.  WAF1 retards S-phase progression primarily by inhibition of cyclin-dependent kinases.

Authors:  V V Ogryzko; P Wong; B H Howard
Journal:  Mol Cell Biol       Date:  1997-08       Impact factor: 4.272

7.  Dependence of NF-kappaB activation and free radical generation on silica-induced TNF-alpha production in macrophages.

Authors:  Y Rojanasakul; J Ye; F Chen; L Wang; N Cheng; V Castranova; V Vallyathan; X Shi
Journal:  Mol Cell Biochem       Date:  1999-10       Impact factor: 3.396

8.  Inhibition of cyclin-dependent kinase 2 by p21 is necessary for retinoblastoma protein-mediated G1 arrest after gamma-irradiation.

Authors:  J Brugarolas; K Moberg; S D Boyd; Y Taya; T Jacks; J A Lees
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-02       Impact factor: 11.205

9.  Fractionation of grape seed extract and identification of gallic acid as one of the major active constituents causing growth inhibition and apoptotic death of DU145 human prostate carcinoma cells.

Authors:  Ravikanth Veluri; Rana P Singh; Zhengjie Liu; John A Thompson; Rajesh Agarwal; Chapla Agarwal
Journal:  Carcinogenesis       Date:  2006-02-10       Impact factor: 4.944

10.  Nitric oxide sensitizes prostate carcinoma cell lines to TRAIL-mediated apoptosis via inactivation of NF-kappa B and inhibition of Bcl-xl expression.

Authors:  Sara Huerta-Yepez; Mario Vega; Ali Jazirehi; Hermes Garban; Fumiya Hongo; Genhong Cheng; Benjamin Bonavida
Journal:  Oncogene       Date:  2004-06-24       Impact factor: 9.867

View more
  22 in total

1.  Excessive MET signaling causes acquired resistance and addiction to MET inhibitors in the MKN45 gastric cancer cell line.

Authors:  Yohei Funakoshi; Toru Mukohara; Hideo Tomioka; Roudy Chiminch Ekyalongo; Yu Kataoka; Yumiko Inui; Yuriko Kawamori; Masanori Toyoda; Naomi Kiyota; Yutaka Fujiwara; Hironobu Minami
Journal:  Invest New Drugs       Date:  2013-04-09       Impact factor: 3.850

2.  Four and a half LIM domains 2 contributes to the development of human tongue squamous cell carcinoma.

Authors:  Qiang Wang; Xiaoying Wang; Xiufen Tian; Ronghua Tang; Xin Xu
Journal:  J Mol Histol       Date:  2016-01-12       Impact factor: 2.611

3.  The regulatory mechanism of LncRNA-mediated ceRNA network in osteosarcoma.

Authors:  Chengsen Lin; Jifeng Miao; Shijie Liao; Yun Liu; Juliang He; Wenyu Feng; Xianxiang Chen; Xiaohong Jiang; Jianhong Liu; Boxiang Li; Qian Huang
Journal:  Sci Rep       Date:  2022-05-24       Impact factor: 4.996

4.  Crude extract of Desmodium gangeticum process anticancer activity via arresting cell cycle in G1 and modulating cell cycle-related protein expression in A549 human lung carcinoma cells.

Authors:  Yuh-Fung Chen; Yi-Hsien Lu; Huei-Yann Tsai
Journal:  Biomedicine (Taipei)       Date:  2022-06-01

5.  Bladder cancer-associated protein, a potential prognostic biomarker in human bladder cancer.

Authors:  José M A Moreira; Gita Ohlsson; Pavel Gromov; Ronald Simon; Guido Sauter; Julio E Celis; Irina Gromova
Journal:  Mol Cell Proteomics       Date:  2009-09-25       Impact factor: 5.911

6.  Altered adenosine-to-inosine RNA editing in human cancer.

Authors:  Nurit Paz; Erez Y Levanon; Ninette Amariglio; Amy B Heimberger; Zvi Ram; Shlomi Constantini; Zohar S Barbash; Konstantin Adamsky; Michal Safran; Avi Hirschberg; Meir Krupsky; Issachar Ben-Dov; Simona Cazacu; Tom Mikkelsen; Chaya Brodie; Eli Eisenberg; Gideon Rechavi
Journal:  Genome Res       Date:  2007-10-01       Impact factor: 9.043

7.  Differential molecular response of larynx cancer cell lines to combined VPA/CDDP treatment.

Authors:  Ewelina Gumbarewicz; Przemko Tylżanowski; Jarogniew Łuszczki; Joanna Kałafut; Arkadiusz Czerwonka; Justyna Szumiło; Anna Wawruszak; Krzysztof Kupisz; Krzysztof Polberg; Jolanta Smok-Kalwat; Andrzej Stepulak
Journal:  Am J Cancer Res       Date:  2021-06-15       Impact factor: 6.166

8.  MicroRNA dysregulation in the spinal cord following traumatic injury.

Authors:  Mónica Yunta; Manuel Nieto-Díaz; Francisco J Esteban; Marcos Caballero-López; Rosa Navarro-Ruíz; David Reigada; D Wolfgang Pita-Thomas; Angela del Águila; Teresa Muñoz-Galdeano; Rodrigo M Maza
Journal:  PLoS One       Date:  2012-04-12       Impact factor: 3.240

9.  Immunoexpression analysis and prognostic value of BLCAP in breast cancer.

Authors:  Irina Gromova; Pavel Gromov; Niels Kroman; Vera Timmermans Wielenga; Ronald Simon; Guido Sauter; José M A Moreira
Journal:  PLoS One       Date:  2012-09-25       Impact factor: 3.240

10.  Transcript- and tissue-specific imprinting of a tumour suppressor gene.

Authors:  Reiner Schulz; Ruth B McCole; Kathryn Woodfine; Andrew J Wood; Mandeep Chahal; David Monk; Gudrun E Moore; Rebecca J Oakey
Journal:  Hum Mol Genet       Date:  2008-10-04       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.